The diagnostic value of interferon- γ Assay in patients with active tuberculosis

Tuberculosis and Respiratory Diseases

Volumn 66, Issue 1, 2009, Pages 13-19

  Park, So Young ^a   Park, Yong Bum ^b   Choi, Jeong Hee ^b   Lee, Jae Young ^b   Kim, Jae Seok ^c   Mo, Eun Kyung ^b,d  

^a Sungkyunkwan University   (South Korea)

^b Departments of Internal Medicine   (South Korea)

^c Hallym University   (South Korea)

^d Kangdong Sacred Heart Hospital   (South Korea)

Author keywords

Active tuberculosis; C reactive protein; Quantiferon TB GOLD

Indexed keywords

C REACTIVE PROTEIN; GAMMA INTERFERON;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PLEURA BIOPSY; PLEURA EFFUSION; PLEURA FLUID; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULOSIS;

EID: 60149100120     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2009.66.1.13     Document Type: Article

References (23)

1. Lönnroth K, Raviglione M. Global epidemiology of tuberculosis: prospects for control. Semin Respir Crit Care Med 2008;29:481-91.
2. Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 2005;293:2767-75.
3. Jasmer RM, Nahid P, Hopewell PC. Clinical practice. Latent tuberculosis infection. N Engl J Med 2002;347:1860-6.
4. Korean Center for Disease Control and Prevention. Annual report on the notified tuberculosis patients in Korea. Seoul: Korean Center for Disease Control and Prevention, Korean Institute for Tuberculosis; 2005.
5. Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 2000;161:1376-95.
6. Mori T, Sakatani M, Yamagishi F, Takashima T, Kawabe Y, Nagao K, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004;170:59-64.
7. Anderson BL, Welch RJ, Litwin CM. Assessment of three commercially available serologic assays for detection of antibodies to Mycobacterium tuberculosis and identification of active tuberculosis. Clin Vaccine Immunol 2008;15:1644-9.
8. Bartu V, Havelkova M, Kopecka E. QuantiFERON- TB Gold in the diagnosis of active tuberculosis. J Int Med Res 2008;36:434-7.
9. Dewan PK, Grinsdale J, Kawamura LM. Low sensitivity of a whole-blood interferon -gamma release assay for detection of active tuberculosis. Clin Infect Dis 2007;44:69-73.
10. Goletti D, Stefania C, Butera O, Amicosante M, Ernst M, Sauzullo I, et al. Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET -Study. PLoS ONE 2008;3: e34l7.
11. Kang YA, Lee HW, Hwang SS, Um SW, Han SK, Shim YS, et al. Usefulness of whole-blood interferon -gamma assay and interferon-gamma enzyme-linked immuno-spot assay in the diagnosis of active pulmonary tuberculosis. Chest 2007;132:959-65.
12. Bellete B, Coberly J, Barnes GL, Ko C, Chaisson RE, Comstock GW, et al. Evaluation of a whole-blood interferon -gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations. Clin Infect Dis 2002;34:1449-56.
13. Ferrara G, Losi M, D'Amico R, Roversi P, Piro R, Meacci M, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006;367:1328-34.
14. Kobashi Y, Obase Y, Fukuda M, Yoshida K, Miyashita N, Oka M. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacterio- sis. Clin Infect Dis 2006;43:1540-6.
15. Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2006;174:736-42.
16. Harada N, Higuchi K, Yoshiyama T, Kawabe Y, Fujita A, Sasaki Y, et al. Comparison of the sensitivity and specificity of two whole blood interferon- gamma assays for M. tuberculosis infection. J Infect 2008;56:348-53.
17. Pai M, Menzies D. Interferon -gamma release assays: what is their role in the diagnosis of active tuberculosis? Clin Infect Dis 2007;44:74-7.
18. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149:177-84.
19. López-Maderuelo D, Arnalich F, Serantes R, Gonzalez A, Codoceo R, Madero R, et al. Interferon -gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 2003;l67:970-5.
20. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV. In vitro production of IFN- gamma correlates with CA repeat polymorphism in the human IFN -gamma gene. Eur J Immunogenet 1999;26:1-3.
21. Oh JH, Yang CS, Noh YK, Kweon YM, Jung SS, Son JW, et al. Polymorphisms of interleukin-10 and tumour necrosis factor-alpha genes are associated with newly diagnosed and recurrent pulmonary tuberculosis. Respirology 2007;12:594-8.
22. Tso HW, Ip WK, Chong WP, Tam CM, Chiang AK, Lau YL. Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun 2005;6:358-63.
23. Sahiratmadja E, Alisjahbana B, de Boer T, Adnan I, Maya A, Danusantoso H, et al. Dynamic changes in pro- and anti-inflammatory cytokine profiles and gamma interferon receptor signaling integrity correlate with tuberculosis disease activity and response to curative treatment. Infect Immun 2007;75:820-9.